Filter
272
Text search:
Fisher,
S.
et
al.
Featured
Recommendations
28
New Publications
39
Language
Document type
No document type
126
Studies & Reports
62
Guidelines
56
Manuals
14
Fact sheets
4
Training Material
3
Resource Platforms
3
Strategic & Response Plan
3
Situation Updates
1
Countries / Regions
Global
12
Sierra Leone
7
Uganda
7
Germany
7
India
6
Western and Central Europe
6
Liberia
5
Latin America and the Carribbean
5
Russia
5
Kenya
4
South Africa
4
Mozambique
4
Brazil
4
Ukraine
4
Myanmar / Burma
4
Nigeria
3
Philippines
3
Syria
3
Chile
3
Paraguay
3
Africa
3
Eastern Europe
3
Guinea
2
Congo, Democratic Republic of
2
USA
2
South Sudan
2
Bangladesh
2
Benin
2
Ecuador
2
Angola
2
Venezuela
2
Guinea-Bissau
1
Ethiopia
1
Ghana
1
Haiti
1
Jordan
1
Zambia
1
Indonesia
1
Malawi
1
Sudan
1
Argentina
1
Eswatini/ Swaziland
1
Austria
1
Switzerland
1
Bolivia
1
Madagascar
1
Yemen
1
Middle East and North Africa
1
South–East Asia Region
1
Eastern Europe and Central Asia
1
Southern Africa
1
Uruguay
1
Portugal
1
Authors & Publishers
Publication Years
Category
Countries
69
Clinical Guidelines
20
Public Health
14
Key Resources
12
Women & Child Health
8
Capacity Building
1
Pharmacy & Technologies
1
Toolboxes
Mental Health
48
COVID-19
48
Planetary Health
17
Ebola & Marburg
16
HIV
14
TB
14
Disability
13
NCDs
11
Caregiver
9
NTDs
6
Rapid Response
5
AMR
5
Natural Hazards
4
Conflict
3
Zika
3
Pharmacy
3
Global Health Education
2
Social Ethics
2
2.0 Rapid Response
2
Polio
1
Refugee
1
Malaria
1
MEASURE Evaluation PRH Working Paper Series
El Manuel Esfera
recommended
Accessed Febr. 6, 2020
manuel de mise en oeuvre de l’OMS
This document aims to help EU/EEA public health authorities in the tracing and management of persons, including healthcare workers, who had contact with COVID-19 cases. It outlines the key steps of contact tracing, including contact identification, listing and follow-up, in the context of the COVID-
...
List of essential medicines for the management of patients admitted in intensive care units with a suspected or confirmed diagnosis of COVID 19. Third version, 1 February 2022
This document is the national level companion to a broader document on health care facility level developed by the WHO Health Emergencies Programme for national level stakeholders
Introduction: Considering the global prevalence of coronavirus disease 2019 (COVID-19), a vaccine is being developed to control the disease as a complementary solution to hygiene measures—and better, in social terms, than social distancing. Given that a vaccine will eventually be produced, informa
...
This document provides guidance to Member States in the WHO European Region that wish to conduct behavioural insights studies related to COVID-19. Studies can be used to monitor public knowledge, risk perceptions, behaviours and trust with the overall aim to inform national COVID-19 outbreak respons
...
Ebola disease and Marburg disease outbreaks continue to occur in Africa, with increased frequency. In addition to resulting in high mortality and morbidity, the outbreaks generate fear and mistrust about the response activities within the communities affected.
Infection prevention and control (IP
...
The Adult Standard Treatment Guidelines and Essential Medicines List for Hospital Level provide a platform for transparency to enable equitable access to safe, effective, and affordable treatment options at hospital level taking into consideration the changing clinical needs of our population and th
...
WHO published guidance for clinicians and health care decision-makers on the use of corticosteroids in patients with COVID-19.
We recommend systemic corticosteroids for the treatment of patients with severe and critical COVID-19. We suggest not to use corticosteroids in the treatment of patients
...
